Impact of Intranasal Insulin on Sympathetic Activity and Cerebral Vasodilation

NCT05153395 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

SUSPENDED

Status

65

Enrollment

OTHER

Sponsor class

Stopped Interim data and power analysis

Conditions

Healthy
Vasodilation
Insulin Resistance
Autonomic Dysfunction
Obesity

Interventions

OTHER: Carbon dioxide breathing
OTHER: Neurovascular Coupling
DRUG: Human insulin

Sponsor

University of Missouri-Columbia